- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- New CRISPR tech targets human genome’s complex code – EurekAlert
- DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies – Genetic Engineering & Biotechnology News
- Why CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking Today – Motley Fool
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- Genome-editing tool TALEN outperforms CRISPR-Cas9 in tightly packed DNA – EurekAlert
- Global CRISPR Technology Market Report 2020: COVID-19 Growth and Change – Market is Expected to Recover to Reach $1.55 Billion in 2023 – Forecast to 2030 – PRNewswire
- Worldwide CRISPR Gene Editing Industry to 2030 – Players Include Abcam, Applied StemCell and Agilent Technologies Among Others – PRNewswire
- Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switch – Genetic Engineering & Biotechnology News
- Why CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking Today – The Motley Fool